secwatch.observer — SEC 8-K summary
======================================

Issuer:     OMEROS CORP (OMER)
CIK:        0001285819
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001437749-24-003287
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Omeros amends royalty deal with DRI, receives $115M for expanded OMIDRIA royalty sale
--------------------------------------------------------------------------------

- Omeros received $115M cash from DRI Healthcare Acquisitions LP for an expanded interest in OMIDRIA royalties.
- Amendment eliminates annual caps on DRI royalties; DRI now receives all U.S. net sales royalties from Jan 2024 through Dec 2031.
- Omeros eligible for two milestone payments of up to $27.5M each in Jan 2026 and Jan 2028 based on U.S. sales thresholds.
- Omeros retains all non-U.S. OMIDRIA royalties from Jan 2024 and all global royalties after Dec 2031; royalty term extends to 2035 in U.S.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285819/000143774924003287/0001437749-24-003287-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285819/000143774924003287/omer20230913_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-003287

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer